nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C8—Fluorouracil—stomach cancer	0.00987	0.322	CbGbCtD
Almotriptan—CYP1A2—Fluorouracil—stomach cancer	0.00764	0.25	CbGbCtD
Almotriptan—Naratriptan—HTR1A—stomach cancer	0.0048	0.244	CrCbGaD
Almotriptan—HTR1B—blood vessel—stomach cancer	0.00452	0.0971	CbGeAlD
Almotriptan—HTR1D—blood vessel—stomach cancer	0.00437	0.094	CbGeAlD
Almotriptan—CYP3A4—Irinotecan—stomach cancer	0.00417	0.136	CbGbCtD
Almotriptan—Rizatriptan—HTR1A—stomach cancer	0.00398	0.202	CrCbGaD
Almotriptan—Zolmitriptan—HTR1A—stomach cancer	0.00364	0.185	CrCbGaD
Almotriptan—CYP2D6—Doxorubicin—stomach cancer	0.00358	0.117	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—stomach cancer	0.00306	0.0999	CbGbCtD
Almotriptan—Sumatriptan—HTR1A—stomach cancer	0.00265	0.135	CrCbGaD
Almotriptan—Eletriptan—CYP2A6—stomach cancer	0.00247	0.126	CrCbGaD
Almotriptan—FMO3—endocrine gland—stomach cancer	0.00235	0.0506	CbGeAlD
Almotriptan—CYP3A4—Doxorubicin—stomach cancer	0.00228	0.0745	CbGbCtD
Almotriptan—Eletriptan—HTR1A—stomach cancer	0.00215	0.109	CrCbGaD
Almotriptan—FMO3—liver—stomach cancer	0.00212	0.0456	CbGeAlD
Almotriptan—CYP2C19—hematopoietic system—stomach cancer	0.00181	0.0389	CbGeAlD
Almotriptan—MAOA—hematopoietic system—stomach cancer	0.00177	0.0381	CbGeAlD
Almotriptan—FMO3—lymph node—stomach cancer	0.00163	0.035	CbGeAlD
Almotriptan—CYP2C8—hematopoietic system—stomach cancer	0.00158	0.034	CbGeAlD
Almotriptan—CYP1A2—hematopoietic system—stomach cancer	0.00148	0.0318	CbGeAlD
Almotriptan—MAOA—pancreas—stomach cancer	0.00144	0.031	CbGeAlD
Almotriptan—HTR1B—endocrine gland—stomach cancer	0.00138	0.0297	CbGeAlD
Almotriptan—CYP2E1—hematopoietic system—stomach cancer	0.00133	0.0286	CbGeAlD
Almotriptan—CYP2C19—digestive system—stomach cancer	0.00126	0.0271	CbGeAlD
Almotriptan—MAOA—digestive system—stomach cancer	0.00123	0.0265	CbGeAlD
Almotriptan—CYP3A4—hematopoietic system—stomach cancer	0.00107	0.023	CbGeAlD
Almotriptan—CYP2D6—hematopoietic system—stomach cancer	0.00105	0.0227	CbGeAlD
Almotriptan—CYP2C19—endocrine gland—stomach cancer	0.00104	0.0224	CbGeAlD
Almotriptan—CYP1A2—digestive system—stomach cancer	0.00103	0.0221	CbGeAlD
Almotriptan—MAOA—endocrine gland—stomach cancer	0.00102	0.0219	CbGeAlD
Almotriptan—CYP2C19—liver—stomach cancer	0.000938	0.0202	CbGeAlD
Almotriptan—CYP2E1—lymphoid tissue—stomach cancer	0.000937	0.0201	CbGeAlD
Almotriptan—CYP2E1—digestive system—stomach cancer	0.000925	0.0199	CbGeAlD
Almotriptan—MAOA—liver—stomach cancer	0.000918	0.0197	CbGeAlD
Almotriptan—CYP2C8—endocrine gland—stomach cancer	0.000908	0.0195	CbGeAlD
Almotriptan—CYP1A2—endocrine gland—stomach cancer	0.00085	0.0183	CbGeAlD
Almotriptan—CYP2C8—liver—stomach cancer	0.000819	0.0176	CbGeAlD
Almotriptan—CYP1A2—liver—stomach cancer	0.000766	0.0165	CbGeAlD
Almotriptan—CYP2E1—endocrine gland—stomach cancer	0.000765	0.0164	CbGeAlD
Almotriptan—CYP3A4—digestive system—stomach cancer	0.000745	0.016	CbGeAlD
Almotriptan—CYP2D6—digestive system—stomach cancer	0.000733	0.0158	CbGeAlD
Almotriptan—MAOA—lymph node—stomach cancer	0.000704	0.0151	CbGeAlD
Almotriptan—CYP2E1—liver—stomach cancer	0.000689	0.0148	CbGeAlD
Almotriptan—Epistaxis—Epirubicin—stomach cancer	0.000666	0.00102	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—stomach cancer	0.000662	0.00101	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—stomach cancer	0.000661	0.00101	CcSEcCtD
Almotriptan—Diarrhoea—Irinotecan—stomach cancer	0.000661	0.00101	CcSEcCtD
Almotriptan—Dry mouth—Capecitabine—stomach cancer	0.000659	0.00101	CcSEcCtD
Almotriptan—Shock—Docetaxel—stomach cancer	0.000657	0.001	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—stomach cancer	0.000655	0.000998	CcSEcCtD
Almotriptan—Pruritus—Fluorouracil—stomach cancer	0.000654	0.000998	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—stomach cancer	0.000653	0.000995	CcSEcCtD
Almotriptan—Confusional state—Capecitabine—stomach cancer	0.000652	0.000994	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—stomach cancer	0.000652	0.000993	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—stomach cancer	0.000649	0.000989	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00064	0.000976	CcSEcCtD
Almotriptan—Dizziness—Irinotecan—stomach cancer	0.000639	0.000974	CcSEcCtD
Almotriptan—Shock—Capecitabine—stomach cancer	0.000636	0.00097	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—stomach cancer	0.000635	0.000969	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—stomach cancer	0.000635	0.000968	CcSEcCtD
Almotriptan—Nervous system disorder—Capecitabine—stomach cancer	0.000634	0.000967	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—stomach cancer	0.000633	0.000965	CcSEcCtD
Almotriptan—Diarrhoea—Fluorouracil—stomach cancer	0.000633	0.000965	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—stomach cancer	0.000632	0.000963	CcSEcCtD
Almotriptan—Tachycardia—Capecitabine—stomach cancer	0.000631	0.000962	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—stomach cancer	0.000631	0.000962	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—stomach cancer	0.000629	0.000959	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—stomach cancer	0.000629	0.000958	CcSEcCtD
Almotriptan—Skin disorder—Capecitabine—stomach cancer	0.000628	0.000957	CcSEcCtD
Almotriptan—Hyperhidrosis—Capecitabine—stomach cancer	0.000625	0.000953	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—stomach cancer	0.000616	0.00094	CcSEcCtD
Almotriptan—CYP3A4—endocrine gland—stomach cancer	0.000615	0.0132	CbGeAlD
Almotriptan—Vomiting—Irinotecan—stomach cancer	0.000614	0.000936	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—stomach cancer	0.000613	0.000935	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—stomach cancer	0.000612	0.000933	CcSEcCtD
Almotriptan—Dizziness—Fluorouracil—stomach cancer	0.000612	0.000933	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—stomach cancer	0.000611	0.000931	CcSEcCtD
Almotriptan—Rash—Irinotecan—stomach cancer	0.000609	0.000928	CcSEcCtD
Almotriptan—Dermatitis—Irinotecan—stomach cancer	0.000608	0.000928	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000608	0.000927	CcSEcCtD
Almotriptan—Chills—Methotrexate—stomach cancer	0.000608	0.000927	CcSEcCtD
Almotriptan—CYP2D6—endocrine gland—stomach cancer	0.000605	0.013	CbGeAlD
Almotriptan—Headache—Irinotecan—stomach cancer	0.000605	0.000923	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—stomach cancer	0.000604	0.000921	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—stomach cancer	0.0006	0.000914	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—stomach cancer	0.000595	0.000908	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—stomach cancer	0.000594	0.000905	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—stomach cancer	0.000593	0.000905	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—stomach cancer	0.000592	0.000903	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—stomach cancer	0.000591	0.000901	CcSEcCtD
Almotriptan—Erythema—Methotrexate—stomach cancer	0.00059	0.000899	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000589	0.000898	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—stomach cancer	0.000588	0.000897	CcSEcCtD
Almotriptan—Vomiting—Fluorouracil—stomach cancer	0.000588	0.000897	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—stomach cancer	0.000588	0.000896	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—stomach cancer	0.000588	0.000896	CcSEcCtD
Almotriptan—Insomnia—Capecitabine—stomach cancer	0.000585	0.000891	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—stomach cancer	0.000584	0.00089	CcSEcCtD
Almotriptan—Rash—Fluorouracil—stomach cancer	0.000583	0.000889	CcSEcCtD
Almotriptan—Dermatitis—Fluorouracil—stomach cancer	0.000583	0.000888	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—stomach cancer	0.000582	0.000887	CcSEcCtD
Almotriptan—Paraesthesia—Capecitabine—stomach cancer	0.00058	0.000885	CcSEcCtD
Almotriptan—Headache—Fluorouracil—stomach cancer	0.00058	0.000884	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—stomach cancer	0.000577	0.00088	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000576	0.000879	CcSEcCtD
Almotriptan—Dyspnoea—Capecitabine—stomach cancer	0.000576	0.000879	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—stomach cancer	0.000576	0.000878	CcSEcCtD
Almotriptan—Nausea—Irinotecan—stomach cancer	0.000574	0.000875	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—stomach cancer	0.000573	0.000873	CcSEcCtD
Almotriptan—Pain—Docetaxel—stomach cancer	0.000571	0.00087	CcSEcCtD
Almotriptan—Back pain—Methotrexate—stomach cancer	0.00057	0.00087	CcSEcCtD
Almotriptan—Dyspepsia—Capecitabine—stomach cancer	0.000569	0.000868	CcSEcCtD
Almotriptan—Chills—Epirubicin—stomach cancer	0.000569	0.000867	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—stomach cancer	0.000565	0.000862	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000558	0.000851	CcSEcCtD
Almotriptan—Fatigue—Capecitabine—stomach cancer	0.000557	0.00085	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—stomach cancer	0.000556	0.000847	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—stomach cancer	0.000555	0.000847	CcSEcCtD
Almotriptan—CYP3A4—liver—stomach cancer	0.000555	0.0119	CbGeAlD
Almotriptan—Pain—Capecitabine—stomach cancer	0.000553	0.000843	CcSEcCtD
Almotriptan—Erythema—Epirubicin—stomach cancer	0.000552	0.000841	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—stomach cancer	0.00055	0.000839	CcSEcCtD
Almotriptan—Nausea—Fluorouracil—stomach cancer	0.000549	0.000838	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—stomach cancer	0.000548	0.000836	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—stomach cancer	0.000547	0.000834	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—stomach cancer	0.000547	0.000834	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—stomach cancer	0.000546	0.000832	CcSEcCtD
Almotriptan—CYP2D6—liver—stomach cancer	0.000546	0.0117	CbGeAlD
Almotriptan—Cardiac disorder—Doxorubicin—stomach cancer	0.000544	0.00083	CcSEcCtD
Almotriptan—Tension—Epirubicin—stomach cancer	0.000541	0.000826	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—stomach cancer	0.00054	0.000824	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—stomach cancer	0.000536	0.000817	CcSEcCtD
Almotriptan—Back pain—Epirubicin—stomach cancer	0.000534	0.000814	CcSEcCtD
Almotriptan—Feeling abnormal—Capecitabine—stomach cancer	0.000533	0.000812	CcSEcCtD
Almotriptan—Malaise—Methotrexate—stomach cancer	0.000532	0.000811	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—stomach cancer	0.00053	0.000808	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—stomach cancer	0.00053	0.000808	CcSEcCtD
Almotriptan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000529	0.000806	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—stomach cancer	0.000528	0.000805	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—stomach cancer	0.000528	0.000805	CcSEcCtD
Almotriptan—Chills—Doxorubicin—stomach cancer	0.000526	0.000802	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—stomach cancer	0.00052	0.000793	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—stomach cancer	0.000514	0.000783	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—stomach cancer	0.000512	0.000781	CcSEcCtD
Almotriptan—Abdominal pain—Capecitabine—stomach cancer	0.000511	0.000779	CcSEcCtD
Almotriptan—Body temperature increased—Capecitabine—stomach cancer	0.000511	0.000779	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—stomach cancer	0.000511	0.000779	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—stomach cancer	0.000511	0.000778	CcSEcCtD
Almotriptan—Agitation—Epirubicin—stomach cancer	0.000507	0.000773	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—stomach cancer	0.000502	0.000765	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—stomach cancer	0.000502	0.000765	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—stomach cancer	0.000502	0.000765	CcSEcCtD
Almotriptan—Tension—Doxorubicin—stomach cancer	0.000501	0.000764	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—stomach cancer	0.0005	0.000762	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000499	0.00076	CcSEcCtD
Almotriptan—Malaise—Epirubicin—stomach cancer	0.000498	0.000759	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—stomach cancer	0.000496	0.000756	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—stomach cancer	0.000496	0.000756	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—stomach cancer	0.000496	0.000756	CcSEcCtD
Almotriptan—Syncope—Epirubicin—stomach cancer	0.000495	0.000754	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—stomach cancer	0.000494	0.000753	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—stomach cancer	0.000492	0.00075	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—stomach cancer	0.000488	0.000743	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—stomach cancer	0.000485	0.00074	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—stomach cancer	0.000485	0.000739	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—stomach cancer	0.000481	0.000734	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—stomach cancer	0.000481	0.000734	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—stomach cancer	0.000479	0.00073	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—stomach cancer	0.000478	0.000729	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—stomach cancer	0.000476	0.000726	CcSEcCtD
Almotriptan—Hypersensitivity—Capecitabine—stomach cancer	0.000476	0.000726	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000474	0.000722	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—stomach cancer	0.000472	0.00072	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—stomach cancer	0.000472	0.00072	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—stomach cancer	0.00047	0.000716	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—stomach cancer	0.00047	0.000716	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—stomach cancer	0.00047	0.000716	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—stomach cancer	0.000469	0.000715	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—stomach cancer	0.000468	0.000714	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—stomach cancer	0.000467	0.000713	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000467	0.000711	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—stomach cancer	0.000465	0.000709	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—stomach cancer	0.000464	0.000708	CcSEcCtD
Almotriptan—Asthenia—Capecitabine—stomach cancer	0.000464	0.000707	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—stomach cancer	0.00046	0.000702	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—stomach cancer	0.000459	0.0007	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—stomach cancer	0.000459	0.000699	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—stomach cancer	0.000458	0.000698	CcSEcCtD
Almotriptan—Pruritus—Capecitabine—stomach cancer	0.000457	0.000697	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—stomach cancer	0.000457	0.000696	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—stomach cancer	0.000454	0.000692	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—stomach cancer	0.000451	0.000688	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—stomach cancer	0.00045	0.000687	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—stomach cancer	0.000449	0.000684	CcSEcCtD
Almotriptan—Shock—Epirubicin—stomach cancer	0.000443	0.000676	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—stomach cancer	0.000442	0.000674	CcSEcCtD
Almotriptan—Diarrhoea—Capecitabine—stomach cancer	0.000442	0.000674	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—stomach cancer	0.000442	0.000673	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—stomach cancer	0.000442	0.000673	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—stomach cancer	0.000441	0.000672	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—stomach cancer	0.00044	0.00067	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000438	0.000668	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—stomach cancer	0.000437	0.000667	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—stomach cancer	0.000435	0.000664	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—stomach cancer	0.000435	0.000664	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—stomach cancer	0.000435	0.000663	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—stomach cancer	0.000435	0.000663	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—stomach cancer	0.000435	0.000663	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—stomach cancer	0.000433	0.00066	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—stomach cancer	0.000432	0.000659	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000432	0.000658	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—stomach cancer	0.000429	0.000655	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—stomach cancer	0.000429	0.000654	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—stomach cancer	0.000428	0.000652	CcSEcCtD
Almotriptan—Dizziness—Capecitabine—stomach cancer	0.000427	0.000652	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—stomach cancer	0.000425	0.000648	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—stomach cancer	0.000425	0.000647	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—stomach cancer	0.000424	0.000646	CcSEcCtD
Almotriptan—Rash—Docetaxel—stomach cancer	0.000421	0.000642	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—stomach cancer	0.000421	0.000641	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—stomach cancer	0.00042	0.000641	CcSEcCtD
Almotriptan—Headache—Docetaxel—stomach cancer	0.000418	0.000638	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000417	0.000635	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000415	0.000633	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—stomach cancer	0.000415	0.000633	CcSEcCtD
Almotriptan—Pain—Methotrexate—stomach cancer	0.000412	0.000627	CcSEcCtD
Almotriptan—Vomiting—Capecitabine—stomach cancer	0.000411	0.000627	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00041	0.000626	CcSEcCtD
Almotriptan—Shock—Doxorubicin—stomach cancer	0.00041	0.000625	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—stomach cancer	0.000409	0.000623	CcSEcCtD
Almotriptan—Rash—Capecitabine—stomach cancer	0.000408	0.000621	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—stomach cancer	0.000407	0.000621	CcSEcCtD
Almotriptan—Dermatitis—Capecitabine—stomach cancer	0.000407	0.000621	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—stomach cancer	0.000407	0.00062	CcSEcCtD
Almotriptan—Headache—Capecitabine—stomach cancer	0.000405	0.000617	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—stomach cancer	0.000405	0.000617	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—stomach cancer	0.000404	0.000617	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000403	0.000614	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—stomach cancer	0.000401	0.000612	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—stomach cancer	0.0004	0.00061	CcSEcCtD
Almotriptan—Nausea—Docetaxel—stomach cancer	0.000397	0.000605	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—stomach cancer	0.000397	0.000605	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—stomach cancer	0.000396	0.000604	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—stomach cancer	0.000393	0.0006	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000389	0.000593	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—stomach cancer	0.000388	0.000592	CcSEcCtD
Almotriptan—Pain—Epirubicin—stomach cancer	0.000385	0.000587	CcSEcCtD
Almotriptan—Nausea—Capecitabine—stomach cancer	0.000384	0.000585	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—stomach cancer	0.00038	0.00058	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—stomach cancer	0.00038	0.00058	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00038	0.000579	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—stomach cancer	0.000377	0.000575	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—stomach cancer	0.000374	0.00057	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—stomach cancer	0.000371	0.000566	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—stomach cancer	0.000371	0.000566	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—stomach cancer	0.00037	0.000565	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000368	0.000561	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—stomach cancer	0.000367	0.000559	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00036	0.000548	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—stomach cancer	0.000359	0.000548	CcSEcCtD
Almotriptan—Pain—Doxorubicin—stomach cancer	0.000356	0.000543	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—stomach cancer	0.000356	0.000543	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—stomach cancer	0.000356	0.000543	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—stomach cancer	0.000355	0.000541	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—stomach cancer	0.000345	0.000526	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—stomach cancer	0.000343	0.000524	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000341	0.000519	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—stomach cancer	0.00034	0.000519	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—stomach cancer	0.000332	0.000506	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—stomach cancer	0.000329	0.000502	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—stomach cancer	0.000329	0.000502	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—stomach cancer	0.000329	0.000502	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—stomach cancer	0.000323	0.000493	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—stomach cancer	0.000319	0.000486	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—stomach cancer	0.000318	0.000485	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—stomach cancer	0.000308	0.00047	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—stomach cancer	0.000307	0.000468	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—stomach cancer	0.000306	0.000466	CcSEcCtD
Almotriptan—Rash—Methotrexate—stomach cancer	0.000303	0.000463	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—stomach cancer	0.000303	0.000462	CcSEcCtD
Almotriptan—Headache—Methotrexate—stomach cancer	0.000301	0.00046	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—stomach cancer	0.000299	0.000456	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—stomach cancer	0.000298	0.000454	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—stomach cancer	0.000295	0.000449	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—stomach cancer	0.000286	0.000437	CcSEcCtD
Almotriptan—Nausea—Methotrexate—stomach cancer	0.000286	0.000436	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—stomach cancer	0.000285	0.000435	CcSEcCtD
Almotriptan—Rash—Epirubicin—stomach cancer	0.000284	0.000433	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—stomach cancer	0.000284	0.000433	CcSEcCtD
Almotriptan—Headache—Epirubicin—stomach cancer	0.000282	0.00043	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—stomach cancer	0.000276	0.00042	CcSEcCtD
Almotriptan—Nausea—Epirubicin—stomach cancer	0.000267	0.000408	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—stomach cancer	0.000265	0.000404	CcSEcCtD
Almotriptan—Rash—Doxorubicin—stomach cancer	0.000263	0.000401	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—stomach cancer	0.000262	0.0004	CcSEcCtD
Almotriptan—Headache—Doxorubicin—stomach cancer	0.000261	0.000398	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—stomach cancer	0.000248	0.000377	CcSEcCtD
Almotriptan—HTR1B—Signaling Pathways—FYN—stomach cancer	4.65e-05	0.000188	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ENO1—stomach cancer	4.6e-05	0.000186	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RORA—stomach cancer	4.6e-05	0.000186	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FBP1—stomach cancer	4.56e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.56e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA1—stomach cancer	4.56e-05	0.000184	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CKB—stomach cancer	4.56e-05	0.000184	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—stomach cancer	4.51e-05	0.000182	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL8—stomach cancer	4.5e-05	0.000182	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PDHA1—stomach cancer	4.48e-05	0.000181	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ECHS1—stomach cancer	4.48e-05	0.000181	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGFR2—stomach cancer	4.46e-05	0.00018	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.42e-05	0.000179	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.41e-05	0.000178	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL8—stomach cancer	4.4e-05	0.000178	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGFR2—stomach cancer	4.37e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALOX5—stomach cancer	4.36e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.35e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDOB—stomach cancer	4.31e-05	0.000174	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLIN2—stomach cancer	4.29e-05	0.000173	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DPYD—stomach cancer	4.29e-05	0.000173	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—stomach cancer	4.25e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMP—stomach cancer	4.21e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FADS1—stomach cancer	4.21e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2A6—stomach cancer	4.2e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA2—stomach cancer	4.17e-05	0.000169	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAV1—stomach cancer	4.16e-05	0.000168	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOA1—stomach cancer	4.15e-05	0.000168	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS2—stomach cancer	4.09e-05	0.000165	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1C3—stomach cancer	4.08e-05	0.000165	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CD44—stomach cancer	4.08e-05	0.000165	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NT5E—stomach cancer	4.06e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PGAM1—stomach cancer	4.06e-05	0.000164	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALOX5—stomach cancer	4.01e-05	0.000162	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS2—stomach cancer	4e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ENO1—stomach cancer	3.98e-05	0.000161	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CAV1—stomach cancer	3.96e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOA1—stomach cancer	3.95e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SREBF2—stomach cancer	3.94e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DPYD—stomach cancer	3.94e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.91e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RORA—stomach cancer	3.9e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.88e-05	0.000157	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CAV1—stomach cancer	3.88e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.88e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLCE1—stomach cancer	3.88e-05	0.000157	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOA1—stomach cancer	3.87e-05	0.000156	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—stomach cancer	3.79e-05	0.000153	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PRKCB—stomach cancer	3.77e-05	0.000152	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6ST—stomach cancer	3.76e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.75e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—UMPS—stomach cancer	3.72e-05	0.00015	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—stomach cancer	3.7e-05	0.00015	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PRKCB—stomach cancer	3.69e-05	0.000149	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6ST—stomach cancer	3.68e-05	0.000149	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—stomach cancer	3.65e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDOB—stomach cancer	3.65e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.64e-05	0.000147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APC—stomach cancer	3.61e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ENO1—stomach cancer	3.55e-05	0.000144	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APC—stomach cancer	3.53e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CD44—stomach cancer	3.53e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.49e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—stomach cancer	3.49e-05	0.000141	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPP2R1A—stomach cancer	3.47e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PDHA1—stomach cancer	3.46e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ECHS1—stomach cancer	3.46e-05	0.00014	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK3—stomach cancer	3.46e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2A6—stomach cancer	3.45e-05	0.000139	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.44e-05	0.000139	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.43e-05	0.000139	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.42e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTP1—stomach cancer	3.4e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX5—stomach cancer	3.39e-05	0.000137	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—stomach cancer	3.38e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—stomach cancer	3.36e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1C3—stomach cancer	3.35e-05	0.000136	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6R—stomach cancer	3.35e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DPYD—stomach cancer	3.34e-05	0.000135	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK1—stomach cancer	3.29e-05	0.000133	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—stomach cancer	3.29e-05	0.000133	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—stomach cancer	3.29e-05	0.000133	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6R—stomach cancer	3.28e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ENO1—stomach cancer	3.27e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMP—stomach cancer	3.25e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FADS1—stomach cancer	3.25e-05	0.000131	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK1—stomach cancer	3.22e-05	0.00013	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—stomach cancer	3.22e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TYMS—stomach cancer	3.16e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CD44—stomach cancer	3.15e-05	0.000127	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—stomach cancer	3.14e-05	0.000127	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—stomach cancer	3.14e-05	0.000127	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—stomach cancer	3.14e-05	0.000127	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—stomach cancer	3.13e-05	0.000127	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—stomach cancer	3.11e-05	0.000126	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—stomach cancer	3.08e-05	0.000124	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—stomach cancer	3.07e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.06e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SREBF2—stomach cancer	3.04e-05	0.000123	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—stomach cancer	3.04e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.03e-05	0.000122	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RHOA—stomach cancer	3.03e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RORA—stomach cancer	3.01e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPP2R1A—stomach cancer	3e-05	0.000121	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—stomach cancer	3e-05	0.000121	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RHOA—stomach cancer	2.96e-05	0.00012	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—stomach cancer	2.95e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—stomach cancer	2.94e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ERCC2—stomach cancer	2.94e-05	0.000119	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—stomach cancer	2.93e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.92e-05	0.000118	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—stomach cancer	2.9e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CD44—stomach cancer	2.9e-05	0.000117	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—stomach cancer	2.87e-05	0.000116	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—stomach cancer	2.85e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.84e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDOB—stomach cancer	2.82e-05	0.000114	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—stomach cancer	2.8e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	2.79e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO1—stomach cancer	2.77e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—stomach cancer	2.76e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—stomach cancer	2.74e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—stomach cancer	2.74e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.72e-05	0.00011	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—stomach cancer	2.7e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.68e-05	0.000108	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—stomach cancer	2.66e-05	0.000107	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—stomach cancer	2.64e-05	0.000107	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—stomach cancer	2.63e-05	0.000106	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX5—stomach cancer	2.62e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—stomach cancer	2.6e-05	0.000105	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	2.59e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—stomach cancer	2.59e-05	0.000105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—stomach cancer	2.58e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DPYD—stomach cancer	2.58e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—stomach cancer	2.55e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOA1—stomach cancer	2.54e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ERCC2—stomach cancer	2.54e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	2.54e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—stomach cancer	2.53e-05	0.000102	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—stomach cancer	2.48e-05	0.0001	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—stomach cancer	2.47e-05	0.0001	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—stomach cancer	2.47e-05	9.99e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.46e-05	9.96e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CD44—stomach cancer	2.45e-05	9.92e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—stomach cancer	2.44e-05	9.87e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—stomach cancer	2.42e-05	9.8e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—stomach cancer	2.42e-05	9.78e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—stomach cancer	2.42e-05	9.77e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—stomach cancer	2.41e-05	9.76e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—stomach cancer	2.4e-05	9.72e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	2.39e-05	9.68e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—stomach cancer	2.39e-05	9.66e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—stomach cancer	2.38e-05	9.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.38e-05	9.63e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—stomach cancer	2.35e-05	9.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	2.34e-05	9.48e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—stomach cancer	2.34e-05	9.45e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—stomach cancer	2.29e-05	9.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—stomach cancer	2.28e-05	9.21e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ERCC2—stomach cancer	2.27e-05	9.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.25e-05	9.11e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—stomach cancer	2.25e-05	9.08e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—stomach cancer	2.24e-05	9.07e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—stomach cancer	2.22e-05	8.98e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—stomach cancer	2.2e-05	8.91e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOA1—stomach cancer	2.2e-05	8.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.19e-05	8.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—stomach cancer	2.16e-05	8.73e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—stomach cancer	2.14e-05	8.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO1—stomach cancer	2.14e-05	8.63e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—stomach cancer	2.13e-05	8.63e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—stomach cancer	2.11e-05	8.54e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.11e-05	8.52e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—stomach cancer	2.09e-05	8.46e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ERCC2—stomach cancer	2.09e-05	8.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.09e-05	8.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—stomach cancer	2.05e-05	8.28e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—stomach cancer	2.04e-05	8.25e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—stomach cancer	2.02e-05	8.16e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—stomach cancer	2.02e-05	8.15e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—stomach cancer	2e-05	8.08e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—stomach cancer	1.99e-05	8.03e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—stomach cancer	1.97e-05	7.96e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOA1—stomach cancer	1.96e-05	7.94e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—stomach cancer	1.96e-05	7.93e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—stomach cancer	1.94e-05	7.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK1—stomach cancer	1.94e-05	7.85e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—stomach cancer	1.94e-05	7.85e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—stomach cancer	1.94e-05	7.84e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—stomach cancer	1.93e-05	7.8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—stomach cancer	1.9e-05	7.69e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK1—stomach cancer	1.9e-05	7.69e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—stomach cancer	1.9e-05	7.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CD44—stomach cancer	1.89e-05	7.66e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—stomach cancer	1.88e-05	7.6e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.88e-05	7.6e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—stomach cancer	1.83e-05	7.42e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—stomach cancer	1.81e-05	7.32e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOA1—stomach cancer	1.81e-05	7.3e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—stomach cancer	1.8e-05	7.26e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—stomach cancer	1.77e-05	7.15e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ERCC2—stomach cancer	1.77e-05	7.15e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—stomach cancer	1.76e-05	7.13e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—stomach cancer	1.74e-05	7.05e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—stomach cancer	1.73e-05	6.99e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	1.69e-05	6.82e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—stomach cancer	1.67e-05	6.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—stomach cancer	1.66e-05	6.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	1.65e-05	6.67e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—stomach cancer	1.63e-05	6.59e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.61e-05	6.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—stomach cancer	1.6e-05	6.46e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—stomach cancer	1.59e-05	6.43e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—stomach cancer	1.58e-05	6.39e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—stomach cancer	1.56e-05	6.31e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—stomach cancer	1.56e-05	6.3e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—stomach cancer	1.56e-05	6.29e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—stomach cancer	1.53e-05	6.2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOA1—stomach cancer	1.53e-05	6.19e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—stomach cancer	1.53e-05	6.17e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—stomach cancer	1.52e-05	6.16e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—stomach cancer	1.49e-05	6.03e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—stomach cancer	1.49e-05	6.02e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—stomach cancer	1.47e-05	5.94e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.46e-05	5.92e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—stomach cancer	1.46e-05	5.91e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—stomach cancer	1.45e-05	5.87e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—stomach cancer	1.43e-05	5.78e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—stomach cancer	1.37e-05	5.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ERCC2—stomach cancer	1.36e-05	5.52e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—stomach cancer	1.36e-05	5.5e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—stomach cancer	1.35e-05	5.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—stomach cancer	1.28e-05	5.19e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—stomach cancer	1.25e-05	5.06e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—stomach cancer	1.21e-05	4.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—stomach cancer	1.18e-05	4.78e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA1—stomach cancer	1.18e-05	4.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—stomach cancer	1.16e-05	4.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—stomach cancer	1.09e-05	4.39e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—stomach cancer	1.06e-05	4.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—stomach cancer	1.04e-05	4.21e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—stomach cancer	9.38e-06	3.79e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—stomach cancer	9.35e-06	3.78e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—stomach cancer	8.95e-06	3.62e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—stomach cancer	8.37e-06	3.39e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—stomach cancer	8.18e-06	3.31e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—stomach cancer	7.7e-06	3.11e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—stomach cancer	6.52e-06	2.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.03e-06	2.04e-05	CbGpPWpGaD
